BioCentury | Jan 2, 2006
Finance

Tier jumpers

...B) Went public during 2005, change calculated from post-IPO valuation; (C) Formed by merger of V.I. Technologies...
BioCentury | Oct 7, 2005
Top Story

Panacos raises $86.6 million

...treat HIV infection in August. PANC, which was formed in March through the merger of V.I. Technologies...
BioCentury | Sep 29, 2005
Financial News

Panacos proposes follow-on

...trial to treat HIV infection. PANC, which was formed in March through the merger of V.I. Technologies...
BioCentury | Aug 23, 2005
Clinical News

Panacos up on Phase IIa HIV data

...next year. The compound has Fast Track designation. PANC was formed by the merger of V.I. Technologies...
BioCentury | Aug 22, 2005
Company News

V.I. Technologies infectious, hematology news

...Pharmaceuticals Inc. and its ticker symbol to PANC. In March, VITX merged with Panacos Pharmaceuticals. V.I. Technologies Inc....
BioCentury | Aug 18, 2005
Company News

Panacos names Marshall CFO

...PANC (formerly V.I. Technologies ) hired Peyton Marshall as EVP and CFO. He replaces John Barr...
...testing to treat HIV infection. PANC, which was formed in March through the merger of V.I. Technologies...
BioCentury | Aug 8, 2005
Analyst Picks & Changes

Analyst picks & changes

...raised his target to $85 from $64 on the earnings news (see "EPS Watch," A16). V.I. Technologies...
BioCentury | Aug 1, 2005
Tools & Techniques

Hunting for Achilles' heel

...I/II trial in HIV infected patients in Thailand during the second half of this year. V.I. Technologies Inc....
BioCentury | Jul 11, 2005
Clinical News

Inactine: Development discontinued

...7, 2004). The company is now seeking shareholder approval to change its name to Panacos. V.I. Technologies Inc....
BioCentury | May 16, 2005
Company News

V.I. Technologies management update

V.I. Technologies Inc. (VITX), Watertown, Mass. Business: Hematology Resigned: John Barr as president WIR Staff Hematology...
Items per page:
1 - 10 of 103
BioCentury | Jan 2, 2006
Finance

Tier jumpers

...B) Went public during 2005, change calculated from post-IPO valuation; (C) Formed by merger of V.I. Technologies...
BioCentury | Oct 7, 2005
Top Story

Panacos raises $86.6 million

...treat HIV infection in August. PANC, which was formed in March through the merger of V.I. Technologies...
BioCentury | Sep 29, 2005
Financial News

Panacos proposes follow-on

...trial to treat HIV infection. PANC, which was formed in March through the merger of V.I. Technologies...
BioCentury | Aug 23, 2005
Clinical News

Panacos up on Phase IIa HIV data

...next year. The compound has Fast Track designation. PANC was formed by the merger of V.I. Technologies...
BioCentury | Aug 22, 2005
Company News

V.I. Technologies infectious, hematology news

...Pharmaceuticals Inc. and its ticker symbol to PANC. In March, VITX merged with Panacos Pharmaceuticals. V.I. Technologies Inc....
BioCentury | Aug 18, 2005
Company News

Panacos names Marshall CFO

...PANC (formerly V.I. Technologies ) hired Peyton Marshall as EVP and CFO. He replaces John Barr...
...testing to treat HIV infection. PANC, which was formed in March through the merger of V.I. Technologies...
BioCentury | Aug 8, 2005
Analyst Picks & Changes

Analyst picks & changes

...raised his target to $85 from $64 on the earnings news (see "EPS Watch," A16). V.I. Technologies...
BioCentury | Aug 1, 2005
Tools & Techniques

Hunting for Achilles' heel

...I/II trial in HIV infected patients in Thailand during the second half of this year. V.I. Technologies Inc....
BioCentury | Jul 11, 2005
Clinical News

Inactine: Development discontinued

...7, 2004). The company is now seeking shareholder approval to change its name to Panacos. V.I. Technologies Inc....
BioCentury | May 16, 2005
Company News

V.I. Technologies management update

V.I. Technologies Inc. (VITX), Watertown, Mass. Business: Hematology Resigned: John Barr as president WIR Staff Hematology...
Items per page:
1 - 10 of 103